Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

To Verify the Efficacy of Acotiamide in Subjects With Functional Dyspepsia, Focusing on the Assessment of Subjective Symptoms.

Trial Profile

To Verify the Efficacy of Acotiamide in Subjects With Functional Dyspepsia, Focusing on the Assessment of Subjective Symptoms.

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 10 Jan 2012

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Acotiamide (Primary)
  • Indications Non-ulcer dyspepsia
  • Focus Registrational; Therapeutic Use

Most Recent Events

  • 10 May 2011 Results assessing outcomes in patients with postprandial distress syndrome with or without epigastric pain syndrome presented at Digestive Disease Week 2011.
  • 10 May 2011 Quality-of-life results presented at Digestive Disease Week 2011.
  • 10 May 2011 Results presented at Digestive Disease Week 2011.

You need to be a logged in or subscribed to view this content Request demo (opens in a new window)

If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top